MedTrace Logo

Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2

NCT02714829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2018-04-04

No results posted yet for this study

Summary

This is a prospective, outcomes assessor-blinded, randomized study to evaluate the efficacy and safety of "Inject BMP(Injectable Ceramics Bone Graft Substitute Containing rhBMP-2)" for socket preservation after extraction of a single-rooted tooth, compared to ExcelOS-inject(Injectable Ceramics Bone Graft Substitute).

Conditions

  • Alveolar Bone Preservation
  • Bone Graft

Interventions

DEVICE

Inject BMP

Injection of ExcelOS-inject(beta-TCP) containing rhBMP-2.

DEVICE

ExcelOS-inject

Injection of ExcelOS-inject(beta-TCP) without rhBMP-2.

Sponsors & Collaborators

  • BioAlpha Inc.

    lead INDUSTRY

Principal Investigators

  • Soon Jung Hwang, Ph.D · Seoul National University Dental Hospital

  • Jong-Rak Hong, Ph.D · Samsung Medical Center

  • Hee-Kyun Oh, Ph.D · Chonnam National University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-09-30
Completion
2018-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714829 on ClinicalTrials.gov